Cell Medica secures £17 million equity investment

Cell Medica Ltd, which is on track to commercialise its first cell therapy in Europe next year, has secured a £17 million equity investment from a group of long-term investors to support its European activities and to finance new operations in Texas.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom